This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Alteplase for Stroke (id = "example-alteplase-for-stroke")
<?xml version="1.0" encoding="UTF-8"?> <EvidenceVariable xmlns="http://hl7.org/fhir"> <id value="example-alteplase-for-stroke"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> "Alteplase for Stroke" is an exposure concept with a detailed dosing instruction that may be used in expressing what an Evidence is about. </p> </div> </text> <title value="Alteplase for Stroke"/> <status value="draft"/> <actual value="true"/> <characteristic> <description value="IV alteplase 0.9 mg/kg (maximum 90 mg) as 10% of dose over 1 minute and 90% over 1 hour"/> <definitionCanonical value="http://example.org/fhir/ActivityDefinition/example-alteplase-dosing"/> </characteristic> </EvidenceVariable>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.